Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003681572 | SCV004399196 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003681572 | SCV005882275 | uncertain significance | not provided | 2024-09-08 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV004731554 | SCV005340484 | likely pathogenic | CACNA1E-related disorder | 2024-05-06 | no assertion criteria provided | clinical testing | The CACNA1E c.4615C>T variant is predicted to result in premature protein termination (p.Arg1539*). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. Nonsense variants in CACNA1E are expected to be pathogenic. This variant is interpreted as likely pathogenic. |